摘要
随着多靶点抗肿瘤药物作用范围的更加全面和广泛,临床联用会存在一定风险和不确定性,现报道1例厄洛替尼联合卡博替尼所致急性毒性反应的病例。
Multi-target anticancer drugs have a more comprehensive and extensive range of action,and there is an uncertain risk in the combination of two drugs.A case of acute toxicity induced by erlotinib combined with cabozantinib is reported in this article.
作者
李涛
贾立静
张娟
胡毅
LI Tao;JIA Lijing;ZHANG Juan;HU Yi(Department of Oncology,the First Medical Center,Chinese PLA General Hospital,Chinese PLA Key Laboratory of Oncology, Ministry of Education Key Laboratory for Tumor-targeting Therapy and Antibody Drugs,Beijing 100853,China;Graduate School of Chinese PLA General Hospital,Medical School of Chinese PLA,Beijing 100853,China;Department of Emergency,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China)
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
2019年第2期278-282,共5页
Acta Academiae Medicinae Sinicae
关键词
厄洛替尼
卡博替尼
药疹
erlotinib
cabozantinib
drug eruption
